Web3 May 2024 · Peripartum cardiomyopathy (PPCM), also known as postpartum cardiomyopathy, is an uncommon form of heart failure that happens during the last month of pregnancy or up to five months after giving birth. Cardiomyopathy literally means heart muscle disease. PPCM is a dilated form of the condition when the heart chambers … Web13 Jan 2009 · Tachycardia induced cardiomyopathy (TIC) is defined as systolic and/or diastolic ventricular dysfunction resulting from a prolonged elevated heart rate which is reversible upon control of the arrhythmia or the heart rate. TIC has been reported in both experimental models and in patients with incessant or very frequent tachyarrhythmia.
Peripartum cardiomyopathy: prognostic factors for long-term …
WebPeripartum cardiomyopathy (PPCM) is a rare condition that affects women in late pregnancy and in the post-partum period. It is characterised by heart failure that presents in the absence of any other identifiable cause. It is … Web1 Apr 2024 · TTE at 6 months postpartum showed a severely reduced LV systolic function (EF 20% to 25%), dilated LV (LV internal dimension in diastole, 8.1 cm), with a diffusely hypokinetic LV. Given the persistent LV dysfunction, she is being evaluated for a heart transplant. Conclusions hanna lyyra kymsote
Tachycardia-induced cardiomyopathy - European Society of …
Web21 Jun 2024 · cardiomyopathy (PPCM) is the idiopathic development of heart failure with reduced ejection fraction ( HFrEF ) at the late stages of pregnancy or during the … Web27 Aug 2024 · A recently developed electrocardiogram (ECG)-based deep learning model has been demonstrated to be effective in identifying cardiomyopathies in clinical and non-clinical settings. 11–13 Currently, there is no information on its value in detecting pregnancy-related cardiomyopathies. Web1 Aug 2024 · Peripartum and Postpartum cardiomyopathy - Etiopathogenesis, Clinical features, Advances in Management. ... • Digoxin- to be used in those with left ventricular systolic dysfunction with ejection fraction <40% while receiving standard therapy…safe in pregnanacy • Digoxin levels between 0.5 and 0.8 ng/mL were beneficial and levels of 1.1 ... hanna mail